Multiple sclerosis immunology : a foundation for current and future treatments /

Multiple sclerosis immunology : a foundation for current and future treatments /

Saved in:
Bibliographic Details
Imprint:New York : Springer, 2013.
Description:1 online resource.
Language:English
Subject:
Multiple Sclerosis.
Multiple Sclerosis -- immunology.
Multiple sclerosis.
Multiple sclerosis -- Immunological aspects.
Multiple sclerosis -- Immunotherapy.
Multiple sclerosis.
Multiple sclerosis -- Immunological aspects.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/9852548
Hidden Bibliographic Details
Other authors / contributors:Yamamura, T. (Takashi), editor of compilation.
Gran, Bruno, editor of compilation.
ISBN:9781461479536 (electronic bk.)
1461479533 (electronic bk.)
9781461479529
Notes:Includes index.
Description based on print version record.
Summary:The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the new MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new therapies. Notably, most if not all of these are immunotherapies. Even the equally exciting field of cell-based therapies and neuro-regeneration may well rely on cells or growth factors that are no less immunomodulators than restorative of myelin and neural cell function. Multiple Sclerosis Immunology looks at MS immunology as the basis for the present andeven morethe future of treatments for this complex autoimmune condition. Both editors are immunologists, as well as clinical neurologists, and appreciate the importance of a sustained dialogue between basic and clinical scientists to ensure that translation is real and not just virtual.
Other form:Print version: Multiple sclerosis immunology 9781461479529
Standard no.:10.1007/978-1-4614-7953-6

MARC

LEADER 00000cam a2200000Ii 4500
001 9852548
003 ICU
005 20140128124600.0
006 m o d
007 cr cnu---unuuu
008 130926s2013 nyua o 001 0 eng d
020 |a 9781461479536 (electronic bk.) 
020 |a 1461479533 (electronic bk.) 
020 |z 9781461479529 
024 7 |a 10.1007/978-1-4614-7953-6  |2 doi 
035 |a (OCoLC)858939393 
040 |a GW5XE  |b eng  |e rda  |e pn  |c GW5XE  |d YDXCP  |d N$T  |d COO  |d ZMC  |d OHS  |d IDEBK 
049 |a CGUA 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.834  |2 23 
090 |a RC377 
096 |a WL 360 
245 0 0 |a Multiple sclerosis immunology :  |b a foundation for current and future treatments /  |c Takashi Yamamura, Bruno Gran, editors. 
264 1 |a New York :  |b Springer,  |c 2013. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
505 0 0 |t Th17 cells in autoimmune inflammation and demyelination in the central nervous system /  |r Vijay K. Kuchroo and Thomas Korn --  |t Regulatory T cells in MS /  |r Barbara B. Gawlik and David A. Hafler --  |t T-bet: A critical regulator of encephalitogenic T Cells /  |r Amy E. Lovett-Racke and Michael K. Racke --  |t Antigen-presenting cells in the Central Nervous System /  |r Nathalie Koning, Juan M. Ilarregui and Juan J. García-Vallejo --  |t The role of B cells in multiple sclerosis /  |r Bernhard Hemmer, Markus C. Kowarik and Martin S. Weber --  |t Diet, gut flora and multiple sclerosis: current research and future perspectives /  |r Takashi Yamamura, and Sachiko Miyake --  |t GM-CSF in autoimmune inflammation of the central nervous system /  |r Mohamed El-Behi, Bogoljub Ciric and Abdolmohamad Rostami --  |t The role of Toll-like receptors in multiple sclerosis and experimental autoimmune encephalomyelitis /  |r Bruno Gran, Mukanthu H. Nyirenda and James Crooks --  |t Macrophages and microglia in experimental autoimmune encephalomyelitis and multiple sclerosis /  |r Manoj Kumar Mishra and V. Wee Yong --  |t Genetics of multiple sclerosis /  |r Julia Y. Mescheriakova and Karim L. Kreft --  |t Gene expression profiling and pathway analysis for identification of molecular targets in MS /  |r Jun-ichi Satoh --  |t Systems biology for the study of multiple sclerosis /  |r Pablo Villoslada and Lawrence Steinman --  |t Checkpoints in the development of pathogenic and regulatory T cells in Experimental Autoimmune Encephalomyelitisa basis for current future interventions in MS /  |r Denise C. Fitzgerald and Stephen M. Anderton --  |t Modeling MS in non-human primates /  |r Prof. Dr. Bert A. 't Hart and S. Anwar Jagessar --  |t A novel concept of treatment in MS: targeting both oligodendrocyte death and inflammatory processes by inhibiting poly (ADP-Ribose) polymerase /  |r Zsolt Illes, Hans Lassmann and Ferenc Gallyas Jr. --  |t Association of MS with other autoimmune diseases /  |r Ali Manouchehrinia and Laura J. Edwards --  |t Current and future treatments of Multiple Sclerosis /  |r Aiden Haghikia and Ralf Gold --  |t Targeting CD52 for the treatment of Multiple Sclerosis /  |r Alasdair Coles and Joanne Jones --  |t Haematopoietic stem cells for the treatment of MS /  |r Sofia Abrahamsson, Miriam Mattoscio and Paolo A. Muraro --  |t Mesenchymal stem cells for the treatment of Multiple Sclerosis. /  |r Laura Lovato, Nicole Kerlero de Rosbo and Antonio Uccelli. 
500 |a Includes index. 
520 |a The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the new MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new therapies. Notably, most if not all of these are immunotherapies. Even the equally exciting field of cell-based therapies and neuro-regeneration may well rely on cells or growth factors that are no less immunomodulators than restorative of myelin and neural cell function. Multiple Sclerosis Immunology looks at MS immunology as the basis for the present andeven morethe future of treatments for this complex autoimmune condition. Both editors are immunologists, as well as clinical neurologists, and appreciate the importance of a sustained dialogue between basic and clinical scientists to ensure that translation is real and not just virtual. 
588 |a Description based on print version record. 
650 2 |a Multiple Sclerosis. 
650 2 |a Multiple Sclerosis  |x immunology. 
650 0 |a Multiple sclerosis.  |0 http://id.loc.gov/authorities/subjects/sh85088374 
650 0 |a Multiple sclerosis  |x Immunological aspects. 
650 0 |a Multiple sclerosis  |x Immunotherapy. 
655 4 |a Electronic books. 
650 7 |a Multiple sclerosis.  |2 fast  |0 http://id.worldcat.org/fast/fst01029018 
650 7 |a Multiple sclerosis  |x Immunological aspects.  |2 fast  |0 http://id.worldcat.org/fast/fst01029027 
700 1 |a Yamamura, T.  |q (Takashi),  |e editor of compilation.  |0 http://id.loc.gov/authorities/names/n2006182550  |1 http://viaf.org/viaf/295142822 
700 1 |a Gran, Bruno,  |e editor of compilation.  |0 http://id.loc.gov/authorities/names/n2014180596  |1 http://viaf.org/viaf/307434373 
776 0 8 |i Print version:  |t Multiple sclerosis immunology  |z 9781461479529  |w (OCoLC)851826669 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4614-7953-6  |y SpringerLink 
903 |a HeVa 
035 |a (ICU)9852548 
929 |a eresource 
999 f f |i c5781024-cb98-5307-b854-37c6e0862f42  |s 0a692123-9047-546f-bea5-14e003d59135 
928 |t Library of Congress classification  |a RC377  |l Online  |c UC-FullText  |u http://dx.doi.org/10.1007/978-1-4614-7953-6  |z SpringerLink  |g ebooks  |i 11495849 

Similar Items